Author

Mazen Issa

Observed name: Mazen ISSA

Institution: Medical College of Wisconsin

Observed institutions: University of Pittsburgh, Medical College of Wisconsin, Botsford Hospital

OpenAlex ID: A5111836636

Impact of Clostridium difficile on Inflammatory Bowel Disease

2007 · Mazen Issa, Aravind Vijayapal, et al. · Clinical Gastroenterology and Hepatology · 575

Vitamin D Deficiency in Patients With Inflammatory Bowel Disease

2011 · Alex Ulitsky, Ashwin N. Ananthakrishnan, et al. · Journal of Parenteral and Enteral Nutrition · 327

Clostridium difficile and inflammatory bowel disease

2008 · Mazen Issa, Ashwin N. Ananthakrishnan, et al. · Inflammatory Bowel Diseases · 257

Budesonide induction and maintenance therapy for Crohnʼs disease during pregnancy

2008 · Dawn B. Beaulieu, Ashwin N. Ananthakrishnan, et al. · Inflammatory Bowel Diseases · 119

Permanent Work Disability in Crohn's Disease

2008 · Ashwin N Ananthakrishnan, Lydia R Weber, et al. · The American Journal of Gastroenterology · 97

History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis

2008 · Ashwin N. Ananthakrishnan, Mazen Issa, et al. · Inflammatory Bowel Diseases · 76

QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States

2010 · Bashar J. Qumseya, Ashwin N. Ananthakrishnan, et al. · Inflammatory Bowel Diseases · 71

Clostridium Difficile and Inflammatory Bowel Disease

2009 · Ashwin N. Ananthakrishnan, Mazen Issa, et al. · Gastroenterology Clinics of North America · 58

Clostridium Difficile and Inflammatory Bowel Disease

2009 · Ashwin N. Ananthakrishnan, Mazen Issa, et al. · Medical Clinics of North America · 43

Impact of Autonomic Dysfunction on Inflammatory Bowel Disease

2010 · Ashwin N. Ananthakrishnan, Mazen Issa, et al. · Journal of Clinical Gastroenterology · 40

Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease?

2009 · Ashwin N. Ananthakrishnan, Dawn B. Beaulieu, et al. · Inflammatory Bowel Diseases · 33

Diet in Inflammatory Bowel Disease

2011 · Mazen Issa, Kia Saeian · Nutrition in Clinical Practice · 21

Durability of infliximab in Crohnʼs disease

2009 · Jason E. Gonzaga, Ashwin N. Ananthakrishnan, et al. · Inflammatory Bowel Diseases · 18

Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease†

2009 · Daniel J. Stein, Ashwin N. Ananthakrishnan, et al. · Inflammatory Bowel Diseases · 17

S1145 Long-Term Impact of Clostridium difficile On Inflammatory Bowel Disease

2009 · Adeeti Chiplunker, Ashwin N. Ananthakrishnan, et al. · Gastroenterology · 14

Impact of pregnancy on health‐related quality of life of patients with inflammatory bowel disease

2012 · Ashwin N ANANTHAKRISHNAN, Yelena ZADVORNOVA, et al. · Journal of Digestive Diseases · 12

Clinical course of Crohnʼs disease following treatment of lymphoma

2011 · Marwa El Mourabet, Jana G. Hashash, et al. · Inflammatory Bowel Diseases · 11

Rifaximin and Treatment of Recurrent Clostridium difficile Infection in Patients with Inflammatory Bowel Disease

2006 · Mazen Issa, Lydia R. Weber, et al. · The American Journal of Gastroenterology · 11

Bowel Rest and Nutrition Therapy in the Management of Active Crohn's Disease

2008 · Mazen Issa, David G. Binion · Nutrition in Clinical Practice · 10

Biologics Are Superior to Immunomodulators in Prevention of Post-Operative Recurrence of Crohn's Disease

2011 · Selamawit Tarekegn, Kristin Oimoen, et al. · Gastroenterology · 4

PDF

Initial Vancomycin Monotherapy is Associated With Higher Rates of Subsequent Clostridium difficile Infection in Inflammatory Bowel Disease Population

2011 · Agnes Libot, Mazen Issa, et al. · Gastroenterology · 4

PDF

S1152 Early Infliximab Infusion in Hospitalized Severe UC Patients: One Year Outcome

2009 · Mukund Venu, Amar S. Naik, et al. · Gastroenterology · 4

Perception and Reality

2008 · Lilani Perera, Ashwin Ananthakrishnan, et al. · The American Journal of Gastroenterology · 4

High Rates of Escalation and Termination of Adalimumab Therapy and Patients Exposed to Infliximab

2011 · Mazen Issa, Yelena Zadvornova, et al. · Gastroenterology · 3

PDF

W1102 Anti-TNF Therapy for Crohn's Disease: Predictors of Dose Escalation and Early Discontinuation By 1 Year of Therapy

2009 · Amar S. Naik, Bashar Qumseya, et al. · Gastroenterology · 3

Works count: 61

Citation count: 1,848

H-index: 14

I10-index: 19